Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

The senescence-associated secretory phenotype and its regulation.

Lopes-Paciencia S, Saint-Germain E, Rowell MC, Ruiz AF, Kalegari P, Ferbeyre G.

Cytokine. 2019 Feb 15;117:15-22. doi: 10.1016/j.cyto.2019.01.013. [Epub ahead of print]

PMID:
30776684
2.

Ribosomal Proteins Control Tumor Suppressor Pathways in Response to Nucleolar Stress.

Lessard F, Brakier-Gingras L, Ferbeyre G.

Bioessays. 2019 Feb 1:e1800183. doi: 10.1002/bies.201800183. [Epub ahead of print] Review.

PMID:
30706966
3.

Circumventing senescence is associated with stem cell properties and metformin sensitivity.

Deschênes-Simard X, Parisotto M, Rowell MC, Le Calvé B, Igelmann S, Moineau-Vallée K, Saint-Germain E, Kalegari P, Bourdeau V, Kottakis F, Bardeesy N, Ferbeyre G.

Aging Cell. 2019 Jan 6:e12889. doi: 10.1111/acel.12889. [Epub ahead of print]

4.

Molecular tools that block maturation of the nuclear lamin A and decelerate cancer cell migration.

Matralis AN, Xanthopoulos D, Huot G, Lopes-Paciencia S, Cole C, de Vries H, Ferbeyre G, Tsantrizos YS.

Bioorg Med Chem. 2018 Nov 1;26(20):5547-5554. doi: 10.1016/j.bmc.2018.10.001. Epub 2018 Oct 4.

PMID:
30309670
5.

Translational and HIF-1α-Dependent Metabolic Reprogramming Underpin Metabolic Plasticity and Responses to Kinase Inhibitors and Biguanides.

Hulea L, Gravel SP, Morita M, Cargnello M, Uchenunu O, Im YK, Lehuédé C, Ma EH, Leibovitch M, McLaughlan S, Blouin MJ, Parisotto M, Papavasiliou V, Lavoie C, Larsson O, Ohh M, Ferreira T, Greenwood C, Bridon G, Avizonis D, Ferbeyre G, Siegel P, Jones RG, Muller W, Ursini-Siegel J, St-Pierre J, Pollak M, Topisirovic I.

Cell Metab. 2018 Dec 4;28(6):817-832.e8. doi: 10.1016/j.cmet.2018.09.001. Epub 2018 Sep 20.

PMID:
30244971
6.

The sequence features that define efficient and specific hAGO2-dependent miRNA silencing guides.

Yan Y, Acevedo M, Mignacca L, Desjardins P, Scott N, Imane R, Quenneville J, Robitaille J, Feghaly A, Gagnon E, Ferbeyre G, Major F.

Nucleic Acids Res. 2018 Sep 19;46(16):8181-8196. doi: 10.1093/nar/gky546.

7.

Cellular senescence, geroscience, cancer and beyond.

Rodier F, Zhou D, Ferbeyre G.

Aging (Albany NY). 2018 Sep 7;10(9):2233-2242. doi: 10.18632/aging.101546. No abstract available.

8.

Senescence-associated ribosome biogenesis defects contributes to cell cycle arrest through the Rb pathway.

Lessard F, Igelmann S, Trahan C, Huot G, Saint-Germain E, Mignacca L, Del Toro N, Lopes-Paciencia S, Le Calvé B, Montero M, Deschênes-Simard X, Bury M, Moiseeva O, Rowell MC, Zorca CE, Zenklusen D, Brakier-Gingras L, Bourdeau V, Oeffinger M, Ferbeyre G.

Nat Cell Biol. 2018 Jul;20(7):789-799. doi: 10.1038/s41556-018-0127-y. Epub 2018 Jun 25.

PMID:
29941930
9.

Quantitative SUMO proteomics reveals the modulation of several PML nuclear body associated proteins and an anti-senescence function of UBC9.

McManus FP, Bourdeau V, Acevedo M, Lopes-Paciencia S, Mignacca L, Lamoliatte F, Rojas Pino JW, Ferbeyre G, Thibault P.

Sci Rep. 2018 May 17;8(1):7754. doi: 10.1038/s41598-018-25150-z.

10.

SOCS1 regulates senescence and ferroptosis by modulating the expression of p53 target genes.

Saint-Germain E, Mignacca L, Vernier M, Bobbala D, Ilangumaran S, Ferbeyre G.

Aging (Albany NY). 2017 Oct 28;9(10):2137-2162. doi: 10.18632/aging.101306.

11.

Aberrant signaling and senescence associated protein degradation.

Ferbeyre G.

Exp Gerontol. 2018 Jul 1;107:50-54. doi: 10.1016/j.exger.2017.06.016. Epub 2017 Jun 27. Review.

PMID:
28658610
12.

Senescence gives insights into the morphogenetic evolution of anamniotes.

Villiard É, Denis JF, Hashemi FS, Igelmann S, Ferbeyre G, Roy S.

Biol Open. 2017 Jun 15;6(6):891-896. doi: 10.1242/bio.025809.

13.

Expression of SOCS1 and the downstream targets of its putative tumor suppressor functions in prostate cancer.

Chevrier M, Bobbala D, Villalobos-Hernandez A, Khan MG, Ramanathan S, Saucier C, Ferbeyre G, Geha S, Ilangumaran S.

BMC Cancer. 2017 Feb 24;17(1):157. doi: 10.1186/s12885-017-3141-8.

14.

Correction: Deficiency of Interleukin-15 Confers Resistance to Obesity by Diminishing Inflammation and Enhancing the Thermogenic Function of Adipose Tissues.

Lacraz G, Rakotoarivelo V, Labbé SM, Vernier M, Noll C, Mayhue M, Stankova J, Schwertani A, Grenier G, Carpentier A, Richard D, Ferbeyre G, Fradette J, Rola-Pleszczynski M, Menendez A, Langlois MF, Ilangumaran S, Ramanathan S.

PLoS One. 2016 Nov 8;11(11):e0166537. doi: 10.1371/journal.pone.0166537. eCollection 2016.

15.

SOCS1 inhibits migration and invasion of prostate cancer cells, attenuates tumor growth and modulates the tumor stroma.

Villalobos-Hernandez A, Bobbala D, Kandhi R, Khan MG, Mayhue M, Dubois CM, Ferbeyre G, Saucier C, Ramanathan S, Ilangumaran S.

Prostate Cancer Prostatic Dis. 2017 Mar;20(1):36-47. doi: 10.1038/pcan.2016.50. Epub 2016 Oct 25.

PMID:
27779203
16.

Deficiency of Interleukin-15 Confers Resistance to Obesity by Diminishing Inflammation and Enhancing the Thermogenic Function of Adipose Tissues.

Lacraz G, Rakotoarivelo V, Labbé SM, Vernier M, Noll C, Mayhue M, Stankova J, Schwertani A, Grenier G, Carpentier A, Richard D, Ferbeyre G, Fradette J, Rola-Pleszczynski M, Menendez A, Langlois MF, Ilangumaran S, Ramanathan S.

PLoS One. 2016 Sep 29;11(9):e0162995. doi: 10.1371/journal.pone.0162995. eCollection 2016. Erratum in: PLoS One. 2016 Nov 8;11(11):e0166537.

17.
18.

A CDK4/6-Dependent Epigenetic Mechanism Protects Cancer Cells from PML-induced Senescence.

Acevedo M, Vernier M, Mignacca L, Lessard F, Huot G, Moiseeva O, Bourdeau V, Ferbeyre G.

Cancer Res. 2016 Jun 1;76(11):3252-64. doi: 10.1158/0008-5472.CAN-15-2347. Epub 2016 Mar 29.

19.

Dataset of STAT5A status in breast cancer.

Mukhopadhyay UK, Cass J, Raptis L, Craig AW, Bourdeau V, Varma S, Gupta SS, Elliott BE, Ferbeyre G.

Data Brief. 2016 Mar 4;7:490-2. doi: 10.1016/j.dib.2016.02.073. eCollection 2016 Jun.

20.

Editorial: Cytokines in inflammation, aging, cancer and obesity.

Ilangumaran S, Ferbeyre G.

Cytokine. 2016 Jun;82:1-3. doi: 10.1016/j.cyto.2016.03.011. Epub 2016 Mar 17. No abstract available.

PMID:
26997465
21.

Permanent farnesylation of lamin A mutants linked to progeria impairs its phosphorylation at serine 22 during interphase.

Moiseeva O, Lopes-Paciencia S, Huot G, Lessard F, Ferbeyre G.

Aging (Albany NY). 2016 Feb;8(2):366-81.

22.

STAT5A is regulated by DNA damage via the tumor suppressor p53.

Mukhopadhyay UK, Cass J, Raptis L, Craig AW, Bourdeau V, Varma S, SenGupta S, Elliott BE, Ferbeyre G.

Cytokine. 2016 Jun;82:70-9. doi: 10.1016/j.cyto.2016.01.013. Epub 2016 Feb 11.

PMID:
26876578
23.

Sponges against miR-19 and miR-155 reactivate the p53-Socs1 axis in hematopoietic cancers.

Mignacca L, Saint-Germain E, Benoit A, Bourdeau V, Moro A, Ferbeyre G.

Cytokine. 2016 Jun;82:80-6. doi: 10.1016/j.cyto.2016.01.015. Epub 2016 Feb 1.

PMID:
26841929
24.

Suppressor of cytokine signaling 1-dependent regulation of the expression and oncogenic functions of p21(CIP1/WAF1) in the liver.

Yeganeh M, Gui Y, Kandhi R, Bobbala D, Tobelaim WS, Saucier C, Yoshimura A, Ferbeyre G, Ramanathan S, Ilangumaran S.

Oncogene. 2016 Aug 11;35(32):4200-11. doi: 10.1038/onc.2015.485. Epub 2016 Jan 4.

PMID:
26725321
25.

The Role of HMGB1 in Radioresistance of Bladder Cancer.

Shrivastava S, Mansure JJ, Almajed W, Cury F, Ferbeyre G, Popovic M, Seuntjens J, Kassouf W.

Mol Cancer Ther. 2016 Mar;15(3):471-9. doi: 10.1158/1535-7163.MCT-15-0581. Epub 2015 Dec 30.

26.

Tumour-promoting role of SOCS1 in colorectal cancer cells.

Tobelaim WS, Beaurivage C, Champagne A, Pomerleau V, Simoneau A, Chababi W, Yeganeh M, Thibault P, Klinck R, Carrier JC, Ferbeyre G, Ilangumaran S, Saucier C.

Sci Rep. 2015 Sep 22;5:14301. doi: 10.1038/srep14301.

27.

Mutant lamin A links prophase to a p53 independent senescence program.

Moiseeva O, Lessard F, Acevedo-Aquino M, Vernier M, Tsantrizos YS, Ferbeyre G.

Cell Cycle. 2015 Aug 3;14(15):2408-21. doi: 10.1080/15384101.2015.1053671. Epub 2015 Jun 1.

28.

Structural and functional characterization of the phosphorylation-dependent interaction between PML and SUMO1.

Cappadocia L, Mascle XH, Bourdeau V, Tremblay-Belzile S, Chaker-Margot M, Lussier-Price M, Wada J, Sakaguchi K, Aubry M, Ferbeyre G, Omichinski JG.

Structure. 2015 Jan 6;23(1):126-138. doi: 10.1016/j.str.2014.10.015. Epub 2014 Dec 11.

29.

Cellular senescence and protein degradation: breaking down cancer.

Deschênes-Simard X, Lessard F, Gaumont-Leclerc MF, Bardeesy N, Ferbeyre G.

Cell Cycle. 2014;13(12):1840-58. doi: 10.4161/cc.29335. Epub 2014 May 27.

30.

Complete senescence: RB and PML share the task.

Vernier M, Ferbeyre G.

Cell Cycle. 2014;13(5):696. doi: 10.4161/cc.28090. Epub 2014 Feb 4. No abstract available.

31.

Engaging a senescent response to cure leukemia.

Bourdeau V, Ferbeyre G.

Nat Med. 2014 Feb;20(2):123-4. doi: 10.1038/nm.3469. No abstract available.

PMID:
24504403
32.

ERKs in cancer: friends or foes?

Deschênes-Simard X, Kottakis F, Meloche S, Ferbeyre G.

Cancer Res. 2014 Jan 15;74(2):412-9. doi: 10.1158/0008-5472.CAN-13-2381. Epub 2014 Jan 9. Review.

33.

CHES1/FOXN3 regulates cell proliferation by repressing PIM2 and protein biosynthesis.

Huot G, Vernier M, Bourdeau V, Doucet L, Saint-Germain E, Gaumont-Leclerc MF, Moro A, Ferbeyre G.

Mol Biol Cell. 2014 Mar;25(5):554-65. doi: 10.1091/mbc.E13-02-0110. Epub 2014 Jan 8.

34.

eIF2α phosphorylation bypasses premature senescence caused by oxidative stress and pro-oxidant antitumor therapies.

Rajesh K, Papadakis AI, Kazimierczak U, Peidis P, Wang S, Ferbeyre G, Kaufman RJ, Koromilas AE.

Aging (Albany NY). 2013 Dec;5(12):884-901.

35.

Metformin, aging and cancer.

Moiseeva O, Deschênes-Simard X, Pollak M, Ferbeyre G.

Aging (Albany NY). 2013 May;5(5):330-1. No abstract available.

36.

Tumor suppressor activity of the ERK/MAPK pathway by promoting selective protein degradation.

Deschênes-Simard X, Gaumont-Leclerc MF, Bourdeau V, Lessard F, Moiseeva O, Forest V, Igelmann S, Mallette FA, Saba-El-Leil MK, Meloche S, Saad F, Mes-Masson AM, Ferbeyre G.

Genes Dev. 2013 Apr 15;27(8):900-15. doi: 10.1101/gad.203984.112. Epub 2013 Apr 18.

37.

Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK/NF-κB activation.

Moiseeva O, Deschênes-Simard X, St-Germain E, Igelmann S, Huot G, Cadar AE, Bourdeau V, Pollak MN, Ferbeyre G.

Aging Cell. 2013 Jun;12(3):489-98. doi: 10.1111/acel.12075. Epub 2013 Apr 23.

38.

Histone deacetylase inhibitors globally enhance h3/h4 tail acetylation without affecting h3 lysine 56 acetylation.

Drogaris P, Villeneuve V, Pomiès C, Lee EH, Bourdeau V, Bonneil E, Ferbeyre G, Verreault A, Thibault P.

Sci Rep. 2012;2:220. doi: 10.1038/srep00220. Epub 2012 Jan 12. No abstract available.

39.

The 5' UTR of HIV-1 full-length mRNA and the Tat viral protein modulate the programmed -1 ribosomal frameshift that generates HIV-1 enzymes.

Charbonneau J, Gendron K, Ferbeyre G, Brakier-Gingras L.

RNA. 2012 Mar;18(3):519-29. doi: 10.1261/rna.030346.111. Epub 2012 Jan 27.

40.

Metformin reduces endogenous reactive oxygen species and associated DNA damage.

Algire C, Moiseeva O, Deschênes-Simard X, Amrein L, Petruccelli L, Birman E, Viollet B, Ferbeyre G, Pollak MN.

Cancer Prev Res (Phila). 2012 Apr;5(4):536-43. doi: 10.1158/1940-6207.CAPR-11-0536. Epub 2012 Jan 18.

41.

SOCS1 controls liver regeneration by regulating HGF signaling in hepatocytes.

Gui Y, Yeganeh M, Ramanathan S, Leblanc C, Pomerleau V, Ferbeyre G, Saucier C, Ilangumaran S.

J Hepatol. 2011 Dec;55(6):1300-8. doi: 10.1016/j.jhep.2011.03.027. Epub 2011 May 19.

PMID:
21703184
42.

Identification of hammerhead ribozymes in all domains of life reveals novel structural variations.

Perreault J, Weinberg Z, Roth A, Popescu O, Chartrand P, Ferbeyre G, Breaker RR.

PLoS Comput Biol. 2011 May;7(5):e1002031. doi: 10.1371/journal.pcbi.1002031. Epub 2011 May 5.

43.

Retinoblastoma-independent regulation of cell proliferation and senescence by the p53-p21 axis in lamin A /C-depleted cells.

Moiseeva O, Bourdeau V, Vernier M, Dabauvalle MC, Ferbeyre G.

Aging Cell. 2011 Oct;10(5):789-97. doi: 10.1111/j.1474-9726.2011.00719.x. Epub 2011 May 29.

44.

ARF1 controls proliferation of breast cancer cells by regulating the retinoblastoma protein.

Boulay PL, Schlienger S, Lewis-Saravalli S, Vitale N, Ferbeyre G, Claing A.

Oncogene. 2011 Sep 8;30(36):3846-61. doi: 10.1038/onc.2011.100. Epub 2011 Apr 11.

PMID:
21478909
45.

Regulation of E2Fs and senescence by PML nuclear bodies.

Vernier M, Bourdeau V, Gaumont-Leclerc MF, Moiseeva O, Bégin V, Saad F, Mes-Masson AM, Ferbeyre G.

Genes Dev. 2011 Jan 1;25(1):41-50. doi: 10.1101/gad.1975111.

46.

The role of Stat5 transcription factors as tumor suppressors or oncogenes.

Ferbeyre G, Moriggl R.

Biochim Biophys Acta. 2011 Jan;1815(1):104-14. doi: 10.1016/j.bbcan.2010.10.004. Epub 2010 Oct 20. Review.

PMID:
20969928
47.

The activity of the HIV-1 IRES is stimulated by oxidative stress and controlled by a negative regulatory element.

Gendron K, Ferbeyre G, Heveker N, Brakier-Gingras L.

Nucleic Acids Res. 2011 Feb;39(3):902-12. doi: 10.1093/nar/gkq885. Epub 2010 Oct 8.

48.

SOCS1, a novel interaction partner of p53 controlling oncogene-induced senescence.

Mallette FA, Calabrese V, Ilangumaran S, Ferbeyre G.

Aging (Albany NY). 2010 Jul;2(7):445-52.

49.

Bile acids in the fountain of youth.

Ferbeyre G.

Aging (Albany NY). 2010 Jul;2(7):383-4. No abstract available.

50.

Transcriptome analysis and tumor suppressor requirements of STAT5-induced senescence.

Mallette FA, Moiseeva O, Calabrese V, Mao B, Gaumont-Leclerc MF, Ferbeyre G.

Ann N Y Acad Sci. 2010 Jun;1197:142-51. doi: 10.1111/j.1749-6632.2010.05192.x.

PMID:
20536843

Supplemental Content

Loading ...
Support Center